Urinary hyaluronan as a marker for the presence of residual transitional cell carcinoma of the urinary bladder.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  European Urology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.EURURO.2005.09.015PMID 16310928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey.

  2005cited by this paper
• Cancer Statistics, 2005

  2005cited by this paper
• A side by side comparison of cytology and biomarkers for bladder cancer detection.

  2004cited by this paper
• A second-look TUR in T1 transitional cell carcinoma: why?

  2004cited by this paper
• Second Transurethral Resection of Superficial Transitional Cell Carcinoma of the Bladder: A Must Even for Experienced Urologists

  2004cited by this paper
• Guidelines on diagnosis and treatment of superficial bladder cancer.

  2004cited by this paper
• Utilidad de los marcadores tumorales en el pronóstico del cáncer transicional de vejiga

  2003cited by this paper
• [The role of tumor markers in prognosing transitional bladder cancer].

  2003cited by this paper
• Current bladder cancer tests: unnecessary or beneficial?

  2003cited by this paper
• Practical determination of hyaluronan by a new noncompetitive fluorescence-based assay on serum of normal and cirrhotic patients.

  2003cited by this paper
• Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid–hyaluronidase and BTA‐Stat tests

  2002cited by this paper
• Segunda resección en pacientes con tumores vesicales Ta-T1

  2001cited by this paper
• Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.

  2001cited by this paper
• [Second resection in patients with Ta-T1 bladder tumors].

  2001cited by this paper
• Current bladder tumor tests: does their projected utility fulfill clinical necessity?

  2001cited by this paper
• The value of a second transurethral resection in evaluating patients with bladder tumors.

  2000cited by this paper
• Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.

  2000cited by this paper
• HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade.

  2000cited by this paper
• Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat.

  1999cited by this paper
• Serum hyaluronan as a disease marker.

  1996cited by this paper
• Natural history of superficial bladder cancer. Prognostic features and long-term disease course.

  1992cited by this paper
• Cytologic and histologic features of superficial bladder cancer.

  1992cited by this paper
• Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder.

  1991cited by this paper
• Superficial bladder cancer: progression and recurrence.

  1983cited by this paper
• Invasive bladder cancer: tumor configuration, lymphatic invasion and survival.

  1983cited by this paper
• Prognostic parameters in superficial bladder cancer: an analysis of 315 cases.

  1982cited by this paper
• Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ.

  1976cited by this paper

• A Case Series Report on Superficial Application of Polydensified Cohesive Matrix Hyaluronic Acid Through Biopsies

  2025cites this paper
• Targeting Hyaluronan Synthesis in Cancer: A Road Less Travelled

  2023cites this paper
• Photoactivatable Metal Organic Framework for Synergistic Ferroptosis and Photodynamic Therapy Using 450 nm Laser

  2022cites this paper
• Methods for Isolating and Analyzing Physiological Hyaluronan: A Review.

  2022cites this paper
• Urinary hyaluronic acid: a versatile marker of bladder cancer

  2020cites this paper
• Urinmarker beim Blasenkarzinom

  2018cites this paper
• The Identification of Proteoglycans and Glycosaminoglycans in Archaeological Human Bones and Teeth

  2015cites this paper
• Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancy

  2015cites this paper
• Novel Oncomarkers Used for Earlier Detection of Bladder Carcinoma

  2014cites this paper
• The Impact of the Receptor of Hyaluronan-Mediated Motility (RHAMM) on Human Urothelial Transitional Cell Cancer of the Bladder

  2013cites this paper
• Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene

  2013cites this paper
• Urine-Based Assays Complementing Cytologic Examination in the Detection of Urothelial Neoplasm

  2012cites this paper
• Relevância clínica da concentração do ácido hialurônico no escarro e em espécimes tumorais de pacientes portadores de carcinomas de pulmão

  2012cites this paper
• B domain containing Tenascin-C: a new urine marker for surveillance of patients with urothelial carcinoma of the urinary bladder?

  2011cites this paper
• Association of hyaluronic acid family members (HAS1, HAS2, and HYAL‐1) with bladder cancer diagnosis and prognosis

  2011cites this paper
• Clinical utility of fluorescence in situ hybridization for prediction of residual tumor after transurethral resection of bladder urothelial carcinoma.

  2011cites this paper
• Immunhistochemische Analyse prognostischer Faktoren von Hyaluronsäure und Hyaluronidase unter Verwendung der Tissue Microarray Technik beim Harnblasenkarzinom

  2011cites this paper
• Utility of Fluorescence In Situ Hybridization for Prediction of Residual Tumor After Transurethral Resection of Bladder Urothelial Carcinoma

  2011cites this paper
• Testing for urinary hyaluronate improves detection and grading of transitional cell carcinoma.

  2011cites this paper
• Microdetermination of hyaluronan in human plasma by high-performance liquid chromatography with a graphitized carbon column and postcolumn fluorometric detection.

  2011cites this paper
• Urine cytology and adjunct markers for detection and surveillance of bladder cancer.

  2010cites this paper
• A Competitive ELISA for Quantifying Serum CD147: Reduction of Soluble CD147 Levels in Cancer Patient Sera

  2010cites this paper
• Papel dos glicosaminoglicanos no urotélio de felinos: revisão de literatura

  2009cites this paper
• Molecular markers for detection, surveillance and prognostication of bladder cancer

  2009cites this paper
• Hyaluronan and hyaluronidase in genitourinary tumors.

  2008cites this paper
• Urinary glycosaminoglycans as biomarker for urothelial injury: is it possible to discriminate damage from recovery?

  2008cites this paper
• Urinary markers in bladder cancer.

  2008influential citation
• Bladder Cancer Urinary Markers in Bladder Cancer

  2008influential citation
• Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.

  2007cites this paper
• Urinary Hyaluronan as a Marker for the Presence of Residual Transitional Cell Carcinoma of the Urinary BladderPasserotti CC, Bonfim A, Martins JRM, et al (Universidade Fed de Säo Paulo, Brazil) Eur Urol 49:71–75, 2006§

  2007cites this paper
• Urinmarker und zellbasierte Nachweisverfahren beim Urothelkarzinom

  2007cites this paper
• Bibliography. Current world literature. Bladder cancer.

  2006cites this paper
• Hyaluronidase : A Negative Regulator of Bladder Cancer HYAL 1v 1 , An Alternatively Spliced Variant of HYAL 1

  2006cites this paper